Doctor of Osteopathy Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Daniel Harmon

Adult Reconstructive Orthopaedic Surgery Cleveland, OH Doctor of Osteopathy

NPI 1790948388 CMS profile 926841

9500 Euclid Ave Bldg A40, Cleveland, OH 44195

Open in the dashboard

General payments

$21,291

136 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Daniel Harmon of Cleveland, OH is reported in the CMS Open Payments database as having received $21,291 across 136 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 65th percentile of Adult Reconstructive Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $6,189 31
2024 General $2,215 13
2023 General $6,230 22
2022 General $898 13
2021 General $2,828 13
2020 General $1,851 31
2019 General $1,080 13

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Daniel Harmon
  • Adult Reconstructive Orthopaedic Surgery median
  • Middle half of Adult Reconstructive Orthopaedic Surgery
  • National median

In program year 2025, general payments to Daniel Harmon were reported at $6,189. Among 1,079 Adult Reconstructive Orthopaedic Surgery profiles paid that year, the median was $1,406 and the middle half received between $318 and $8,709.

Show as a table
Year Daniel Harmon Adult Reconstructive Orthopaedic Surgery median Middle half National median
2019 $1,080 $1,416 $292–$9,336 $163
2020 $1,851 $647 $141–$6,474 $114
2021 $2,828 $1,073 $211–$6,497 $132
2022 $898 $1,217 $236–$6,299 $149
2023 $6,230 $1,082 $246–$6,818 $160
2024 $2,215 $1,575 $323–$8,944 $164
2025 $6,189 $1,406 $318–$8,709 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Smith+Nephew, Inc. $5,075 5 payments
  2. DePuy Synthes Products, Inc. $5,011 14 payments
  3. Stryker Corporation $4,375 63 payments
  4. Medical Device Business Services, Inc. $3,167 3 payments
  5. Zimmer Biomet Holdings, Inc. $1,281 16 payments
  6. Integra LifeSciences Corporation $840 7 payments
  7. DePuy Synthes Sales Inc. $608 10 payments
  8. Baudax Bio Inc. $251 3 payments
  9. Bone Support Inc. $147 1 payment
  10. Aroa Biosurgery Incorporated $110 3 payments
  11. Other $427 11 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $7,822 120 payments
  2. Consulting Fee $6,751 3 payments
  3. Travel and Lodging $6,485 12 payments
  4. Education $233 1 payment
Products named General payments · program years 2019–2025
  1. REAL INTELLIGENCE $5,075 5 payments
  2. RI Hip Navigation $5,039 3 payments
  3. JOURNEY II $5,004 2 payments
  4. BIRMINGHAM HIP $5,004 2 payments
  5. Kincise $3,112 14 payments
  6. Velys $1,800 1 payment
  7. ACTIS $1,800 1 payment
  8. ATTUNE $1,800 1 payment
  9. MAKO $1,431 14 payments
  10. TRIATHLON $646 10 payments
  11. Other $9,265 124 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 5 drugs

Part D claims

308

Median for Orthopedic Surgery: 203

Drug cost

$4,151

Median for Orthopedic Surgery: $1,433

Branded share of claims

0%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Celecoxib Generic 167 $3,703
Amoxicillin Generic 71 $179
Meloxicam Generic 36 $114
Tramadol Hcl Generic 15 $97
Clindamycin Hcl Generic 19 $58

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 40 billing codes

Paid by Medicare

$155,973

Medicare's payments for the services billed

Medicare patients

360

Average age 75

Services billed

743

209 women, 151 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Diabetes 29%
Chronic kidney disease 27%
Depression 27%
Ischemic heart disease 26%
Atrial fibrillation 23%
Heart failure 19%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

136 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Adult Reconstructive Orthopaedic Surgery in Ohio

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record